A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Clinical trial NCT05622890 · UNKNOWN

Trial details

NCT number: NCT05622890
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2022-08-18
Primary completion: 2023-04-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.